These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

73 related items for PubMed ID: 1505173

  • 1. [Potassium canrenoate and the combination of potassium canrenoate-butizide in the therapy of light to moderate arterial hypertension].
    Morabito S, Fabiano M, Puliti M, Palumbo R, Marinelli R, Simonetti BM, Pierucci A.
    Clin Ter; 1992 Jul; 141(7):23-8. PubMed ID: 1505173
    [Abstract] [Full Text] [Related]

  • 2. Eprosartan provides safe and effective long-term maintenance of blood pressure control in patients with mild to moderate essential hypertension.
    Levine B.
    Curr Med Res Opin; 2001 Jul; 17(1):8-17. PubMed ID: 11464450
    [Abstract] [Full Text] [Related]

  • 3. [Antihypertensive efficacy and effects on intra and extracellular electrolytes of a canrenoate potassium-butizide combination].
    Costa FV, Borghi C, Mussi A, Ambrosioni E.
    Minerva Cardioangiol; 1988 Oct; 36(10):503-7. PubMed ID: 3226562
    [No Abstract] [Full Text] [Related]

  • 4. [Lowering of blood pressure, blood pressure amplitude and heart rate by treatment with valsartan or valsartan/hydrochlorothiazide. Results of an open observation study of 11,447 hypertensives].
    Weisser B, Vetter H, Mengden T.
    Dtsch Med Wochenschr; 2003 Mar 14; 128(11):541-4. PubMed ID: 12635025
    [Abstract] [Full Text] [Related]

  • 5. Different sensitivity to hydrochlorothiazide and to potassium-canrenoate among essential hypertensive patients.
    Glorioso N, Melis MG, Manunta P, Troffa C, Tonolo G, Soro A, Madeddu P, Pazzola A, Pala F, Cusi D.
    Clin Exp Hypertens; 1993 Mar 14; 15 Suppl 1():187-96. PubMed ID: 8513309
    [Abstract] [Full Text] [Related]

  • 6. Double-blind, parallel, comparative multicentre study of a new combination of diltiazem and hydrochlorothiazide with individual components in patients with mild or moderate hypertension.
    Manning G, Joy A, Mathias CJ, McDonald CJ, Millar-Craig MW.
    J Hum Hypertens; 1996 Jul 14; 10(7):443-8. PubMed ID: 8880557
    [Abstract] [Full Text] [Related]

  • 7. Antihypertensive properties of tiapamil (RO 11-1781)--a new calcium antagonist--in patients with mild and moderate essential hypertension.
    Velasco M, Morillo J, Urbina A, Kögler P, Leishman B, Pasquier M, Hernändez-Pieretti O.
    Int J Clin Pharmacol Res; 1987 Jul 14; 7(6):443-54. PubMed ID: 3440635
    [Abstract] [Full Text] [Related]

  • 8. The effects of antihypertensive combination therapy on lipid and glucose metabolism: hydrochlorothiazide plus sotalol vs. hydrochlorothiazide plus captopril.
    Middeke M, Richter WO, Schwandt P, Holzgreve H.
    Int J Clin Pharmacol Ther; 1997 Jun 14; 35(6):231-4. PubMed ID: 9208337
    [Abstract] [Full Text] [Related]

  • 9. Blood pressure and aortic elastic properties--verapamil SR/trandolapril compared to a metoprolol/hydrochlorothiazide combination therapy.
    Breithaupt-Grögler K, Gerhardt G, Lehmann G, Notter T, Belz GG.
    Int J Clin Pharmacol Ther; 1998 Aug 14; 36(8):425-31. PubMed ID: 9726695
    [Abstract] [Full Text] [Related]

  • 10. [Effectiveness and tolerance of fosinopril in the treatment of arterial hypertension of mild and medium severity].
    Rosolová H, Cech J, Sefrna F.
    Vnitr Lek; 2001 Dec 14; 47(12):834-9. PubMed ID: 11826546
    [Abstract] [Full Text] [Related]

  • 11. Enalapril and enalapril-hydrochlorothiazide in the treatment of essential hypertension. The Enalapril-Hydrochlorothiazide in Essential Hypertension Canadian Working Group.
    Clin Ther; 1993 Dec 14; 15(2):364-73. PubMed ID: 8519044
    [Abstract] [Full Text] [Related]

  • 12. Efficacy and tolerability of combination therapy with valsartan/hydrochlorothiazide in the initial treatment of severe hypertension.
    Calhoun DA, Glazer RD, Pettyjohn FS, Coenen PD, Zhao Y, Grosso A.
    Curr Med Res Opin; 2008 Aug 14; 24(8):2303-11. PubMed ID: 18593517
    [Abstract] [Full Text] [Related]

  • 13. Shifting trends in the pharmacologic treatment of hypertension in a Nigerian tertiary hospital: a real-world evaluation of the efficacy, safety, rationality and pharmaco-economics of old and newer antihypertensive drugs.
    Adigun AQ, Ishola DA, Akintomide AO, Ajayi AA.
    J Hum Hypertens; 2003 Apr 14; 17(4):277-85. PubMed ID: 12714973
    [Abstract] [Full Text] [Related]

  • 14. [A new drug combination: metipranolol with butizide in the treatment of arterial hypertension].
    De Cesaris R, Balestrazzi M, Procaccio P, Dell'Orco M.
    Clin Ter; 1981 Oct 15; 99(1):43-7. PubMed ID: 6118217
    [No Abstract] [Full Text] [Related]

  • 15. [Essential arterial hypertension. A therapeutic proposal].
    Di Veroli C, Iugoli AR.
    Arch Sci Med (Torino); 1981 Oct 15; 138(3):355-60. PubMed ID: 6119065
    [Abstract] [Full Text] [Related]

  • 16. Efficacy and tolerability of enalapril (20 mg)/hydrochlorothiazide (12.5 mg) combination therapy in essential hypertension.
    Strocchi E, Bossini A, Ranieri G, Filitti V.
    Clin Ther; 1991 Oct 15; 13(6):737-46. PubMed ID: 1790548
    [Abstract] [Full Text] [Related]

  • 17. Double-blind, placebo-controlled trial of twice-daily nifedipine as a step-2 agent in mild essential hypertension.
    Svetkey LP, Weinberger MH, Gavras H, Gavras I, Brown TS, Deterding J, Klotman PE.
    J Clin Hypertens; 1987 Dec 15; 3(4):579-88. PubMed ID: 3330988
    [Abstract] [Full Text] [Related]

  • 18. Treatment of hypertension in the very old.
    Otterstad JE, Ruilope LM.
    Int J Clin Pract Suppl; 2000 Nov 15; (114):10-9. PubMed ID: 11221289
    [Abstract] [Full Text] [Related]

  • 19. Antihypertensive and hypokalemic effects of isobutyl hydrochlorothiazide alone and in combination with spironolactone.
    Lochaya S, Suvachittanont O, Triyanond K.
    J Med Assoc Thai; 1985 Aug 15; 68(8):399-407. PubMed ID: 3906011
    [No Abstract] [Full Text] [Related]

  • 20. A randomized, comparative study evaluating the efficacy and tolerability of losartan-low dose chlorthalidone (6.25 mg) combination with losartan-hydrochlorothiazide (12.5 mg) combination in Indian patients with mild-to-moderate essential hypertension.
    Pareek A, Basavanagowdappa H, Zawar S, Kumar A, Chandurkar N.
    Expert Opin Pharmacother; 2009 Jul 15; 10(10):1529-36. PubMed ID: 19514864
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.